Hüttemann H, Blaschke G
Institute of Pharmaceutical Chemistry, University of Münster, Germany.
J Chromatogr B Biomed Sci Appl. 1999 Jun 11;729(1-2):33-41. doi: 10.1016/s0378-4347(99)00115-2.
A method for achiral separation of the racemic hypolipidaemic agent ciprofibrate and its main metabolite ciprofibrate glucuronide by capillary electrophoresis (CE) was developed. The glucuronide was isolated from urine by chromatographic procedures and characterized by alkaline as well as enzymatic hydrolysis and mass spectrometric and nuclear magnetic resonance experiments. Chiral discrimination of the ciprofibrate enantiomers and their diastereomeric glucuronides by CE was achieved by the use of gamma-cyclodextrin as buffer additive. The fractionated crystallization of ciprofibrate yielded the R-(+)-enantiomer as less soluble diastereomeric salt with (+)-1-phenylethylamine. This allowed the identification of the enantiomers of ciprofibrate as well as the diastereomeric glucuronides of ciprofibrate by CE. In a study with three volunteers inter- and intra-individual differences of ratios of both ciprofibrate glucuronides in urine were observed. After oral administration of a single dose of the racemate the S-ciprofibrate glucuronide was mainly excreted in the first time intervals, in the last time intervals the R-glucuronide dominated.
开发了一种通过毛细管电泳(CE)对外消旋降血脂药物环丙贝特及其主要代谢物环丙贝特葡糖醛酸苷进行非手性分离的方法。通过色谱程序从尿液中分离出葡糖醛酸苷,并通过碱性及酶促水解、质谱和核磁共振实验对其进行表征。通过使用γ-环糊精作为缓冲添加剂,实现了通过CE对环丙贝特对映体及其非对映体葡糖醛酸苷的手性鉴别。环丙贝特的分步结晶得到R-(+)-对映体,其为与(+)-1-苯乙胺形成的较难溶解的非对映体盐。这使得能够通过CE鉴定环丙贝特的对映体以及环丙贝特的非对映体葡糖醛酸苷。在一项针对三名志愿者的研究中,观察到尿液中环丙贝特两种葡糖醛酸苷比例的个体间和个体内差异。口服单剂量外消旋体后,S-环丙贝特葡糖醛酸苷主要在最初的时间间隔内排泄,在最后的时间间隔内R-葡糖醛酸苷占主导。